These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 9351876

  • 1. Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease.
    Piovesan A, Berruti A, Torta M, Cannone R, Sperone P, Panero A, Gorzegno G, Termine A, Dogliotti L, Angeli A.
    Calcif Tissue Int; 1997 Nov; 61(5):362-9. PubMed ID: 9351876
    [Abstract] [Full Text] [Related]

  • 2. Serum alkaline phosphatase isoenzyme activities in canine malignant mammary neoplasms with and without osseous transformation.
    Karayannopoulou M, Polizopoulou ZS, Koutinas AF, Fytianou A, Roubies N, Kaldrymidou E, Tsioli V, Patsikas MN, Constantinidis TC, Koutinas CK.
    Vet Clin Pathol; 2006 Sep; 35(3):287-90. PubMed ID: 16967410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
    Francini G, Gonnelli S, Petrioli R, Bruni S, Marsili S, Aquino A, Camporeale A.
    Cancer Epidemiol Biomarkers Prev; 1993 Sep; 2(2):125-9. PubMed ID: 8467247
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma.
    Garzotto CK, Berg J, Hoffmann WE, Rand WM.
    J Vet Intern Med; 2000 Sep; 14(6):587-92. PubMed ID: 11110379
    [Abstract] [Full Text] [Related]

  • 8. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
    Body JJ, Dumon JC, Blocklet D, Darte C.
    Eur J Cancer; 1997 Sep; 33(10):1578-82. PubMed ID: 9389918
    [Abstract] [Full Text] [Related]

  • 9. Transient increase in total serum alkaline phosphatase predicts radiological response to systemic therapy in breast cancer patients with osteolytic and mixed bone metastases.
    Berruti A, Osella G, Raucci CA, Roncari A, Dogliotti L.
    Oncology; 1993 Sep; 50(4):218-21. PubMed ID: 8497373
    [Abstract] [Full Text] [Related]

  • 10. Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer.
    Berruti A, Sperone P, Fasolis G, Torta M, Fontana D, Dogliotti L, Angeli A.
    Prostate; 1997 Dec 01; 33(4):252-5. PubMed ID: 9397197
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biochemical prediction of response of bone metastases to treatment.
    Coleman RE, Whitaker KB, Moss DW, Mashiter G, Fogelman I, Rubens RD.
    Br J Cancer; 1988 Aug 01; 58(2):205-10. PubMed ID: 3262366
    [Abstract] [Full Text] [Related]

  • 13. New and traditional serum markers of bone metabolism in the detection of skeletal metastases.
    Plebani M, Bernardi D, Zaninotto M, De Paoli M, Secchiero S, Sciacovelli L.
    Clin Biochem; 1996 Feb 01; 29(1):67-72. PubMed ID: 8929827
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases.
    Berruti A, Dogliotti L, Tucci M, Tarabuzzi R, Guercio S, Torta M, Tampellini M, Dovio A, Poggio M, Scarpa RM, Angeli A.
    Int J Biol Markers; 2002 Feb 01; 17(4):244-52. PubMed ID: 12521128
    [Abstract] [Full Text] [Related]

  • 17. Age related changes in biochemical markers of bone metabolism in horses.
    Price JS, Jackson B, Eastell R, Goodship AE, Blumsohn A, Wright I, Stoneham S, Lanyon LE, Russell RG.
    Equine Vet J; 1995 May 01; 27(3):201-7. PubMed ID: 7556047
    [Abstract] [Full Text] [Related]

  • 18. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E, González Parra E, de la Piedra C, Caramelo C, Rapado A.
    Miner Electrolyte Metab; 1994 May 01; 20(5):259-64. PubMed ID: 7700213
    [Abstract] [Full Text] [Related]

  • 19. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D.
    Ann Clin Biochem; 1994 Jul 01; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [Abstract] [Full Text] [Related]

  • 20. Bone turnover in hyperthyroidism before and after thyrostatic management.
    Isaia GC, Roggia C, Gola D, Stefano MD, Gallone G, Aimo G, Ardissone P, Mussetta M.
    J Endocrinol Invest; 2000 Dec 01; 23(11):727-31. PubMed ID: 11194705
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.